Get started
JUBILANT PHARMOVA LIMITEDJUBILANT PHARMOVA LIMITEDJUBILANT PHARMOVA LIMITED

JUBILANT PHARMOVA LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

JUBLPHARMA chart

Key stats

Market capitalization
‪109.06 B‬INR
Dividend yield (indicated)
0.73%
Price to earnings Ratio (TTM)
288.50
Basic EPS (TTM)
2.35INR
Net income (FY)
‪−609.80 M‬INR
Revenue (FY)
‪62.64 B‬INR
Shares float
‪65.95 M‬
Beta (1Y)
0.84

About JUBILANT PHARMOVA LIMITED

Sector
Health Technology
Headquarters
Noida
Employees (FY)
‪5 K‬
Website
jubilantpharmova.com
Founded
1978
ISIN
INE700A01033
FIGI
BBG000D1PZR8
Jubilant Pharmova Ltd. engages in the provision of basic organic chemicals. It operates through the following segments: Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation, Generics, and Proprietary Novel Drugs. The Radiopharma segment is involved in products for diagnosis and treatment of various diseases, including Pulmonary Embolism, Cancer, Coronary Artery Diseaseand many others. The Allergy Immunotherapy segment provides diagnostic devices for skin testing. The CDMO Sterile Injectables segment offer manufacturing services including sterile fill and finish injectables, full-service ophthalmic offer, and ampoules. The Generics segment includes development, manufacturing, distribution, sales and marketing of generics formulations. The CRDMO segment relates to drug discovery and development services. The company was founded on June 21, 1978 and is headquartered in Noida, India.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of JUBLPHARMA is 676.65 INR — it has decreased by 0.86% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange JUBILANT PHARMOVA LIMITED stocks are traded under the ticker JUBLPHARMA.
JUBILANT PHARMOVA LIMITED is going to release the next earnings report on May 31, 2024. Keep track of upcoming events with our Earnings Calendar.
JUBLPHARMA stock is 4.86% volatile and has beta coefficient of 0.84. Check out the list of the most volatile stocks — is JUBILANT PHARMOVA LIMITED there?
JUBLPHARMA earnings for the last quarter are 8.97 INR per share, whereas the estimation was 4.30 INR resulting in a 108.60% surprise. The estimated earnings for the next quarter are 4.80 INR per share. See more details about JUBILANT PHARMOVA LIMITED earnings.
JUBILANT PHARMOVA LIMITED revenue for the last quarter amounts to ‪16.78 B‬ INR despite the estimated figure of ‪15.49 B‬ INR. In the next quarter revenue is expected to reach ‪15.03 B‬ INR.
Yes, you can track JUBILANT PHARMOVA LIMITED financials in yearly and quarterly reports right on TradingView.
JUBLPHARMA stock has fallen by 1.23% compared to the previous week, the month change is a 20.72% rise, over the last year JUBILANT PHARMOVA LIMITED has showed a 124.80% increase.
JUBLPHARMA net income for the last quarter is ‪668.00 M‬ INR, while the quarter before that showed ‪625.00 M‬ INR of net income which accounts for 6.88% change. Track more JUBILANT PHARMOVA LIMITED financial stats to get the full picture.
Today JUBILANT PHARMOVA LIMITED has the market capitalization of ‪108.72 B‬, it has increased by 1.43% over the last week.
Yes, JUBLPHARMA dividends are paid annually. The last dividend per share was 5.00 INR. As of today, Dividend Yield (TTM)% is 0.73%. Tracking JUBILANT PHARMOVA LIMITED dividends might help you take more informed decisions.
Like other stocks, JUBLPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JUBILANT PHARMOVA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
JUBLPHARMA reached its all-time high on Feb 3, 2021 with the price of 1046.75 INR, and its all-time low was 65.10 INR and was reached on Aug 28, 2013.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has ‪5.00 K‬ employees. See our rating of the largest employees — is JUBILANT PHARMOVA LIMITED on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JUBILANT PHARMOVA LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JUBILANT PHARMOVA LIMITED stock shows the strong buy signal. See more of JUBILANT PHARMOVA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JUBILANT PHARMOVA LIMITED EBITDA is ‪8.49 B‬ INR, and current EBITDA margin is 12.15%. See more stats in JUBILANT PHARMOVA LIMITED financial statements.